Use of radionuclides in metastatic prostate cancer: pain relief and beyond

Salil Vengalil, Joe M O'Sullivan, Christopher C Parker

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of radionuclides in the dynamic treatment landscape of metastatic prostate cancer in light of new evidence demonstrating benefit beyond palliation.
Original languageEnglish
Pages (from-to)310-5
Number of pages6
JournalCurrent opinion in supportive and palliative care
Volume6
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Use of radionuclides in metastatic prostate cancer: pain relief and beyond'. Together they form a unique fingerprint.

  • Cite this